Drug intelligence / Profile preview

oligopeptide-10

Development stage
Unknown
Lead developer
Grant Industries
Modality
Peptides
Administration
Topical
01

Overview

Oligopeptide-10 is a synthetic bioactive peptide consisting of 15 amino acids with the sequence Phe-Ala-Lys-Ala-Leu-Lys-Ala-Leu-Leu-Lys-Ala-Leu-Lys-Ala-Leu. It is primarily utilized as an antimicrobial agent in topical cosmetic formulations for the treatment of acne. The peptide exhibits potent activity against Gram-positive bacteria, particularly *Cutibacterium acnes* (formerly *Propionibacterium acnes*), by binding to negatively charged lipoteichoic acids (LTA) on the bacterial cell wall. This binding induces osmotic imbalances and mechanical disruption of the cell membrane, resulting in bacterial cell death without the enzymatic pathways that typically lead to antibiotic resistance. It is often formulated alongside salicylic acid to provide synergistic anti-acne effects and is marketed under trade names such as Granactive Oligopeptide-10 for use in serums, cleansers, and patches.

Brand names
Granactive Oligopeptide-10
Other names
CAS 466691-40-7CAS466691-40-7CAS-466691-40-7
02

Targets

LTA (Lymphotoxin-alpha)

Beyond the preview

Go deeper on oligopeptide-10.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oligopeptide-10.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call